Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.71
+0.05 (0.58%)
At close: Dec 5, 2025, 4:00 PM EST
8.88
+0.17 (1.95%)
After-hours: Dec 5, 2025, 7:59 PM EST
Zevra Therapeutics Employees
Zevra Therapeutics had 59 employees as of December 31, 2024. The number of employees decreased by 10 or -14.49% compared to the previous year.
Employees
59
Change (1Y)
-10
Growth (1Y)
-14.49%
Revenue / Employee
$1,430,305
Profits / Employee
$508,746
Market Cap
490.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZVRA News
- 4 days ago - Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - GlobeNewsWire
- 15 days ago - Zevra Therapeutics, Inc. Announces CFO Transition - GlobeNewsWire
- 4 weeks ago - Zevra Therapeutics, Inc. (ZVRA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Zevra Reports Third Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 5 weeks ago - Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 5 weeks ago - Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call - GlobeNewsWire
- 2 months ago - Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate) - GlobeNewsWire